Human Adjuvant Disease Following Augmentation Mammoplasty

Stephen J. Brozena; Neil A. Fenske; C. Wayne Cruse; Carmen G. Espinoza; Frank B. Vasey; Bernard F. Germain; Luis R. Espinoza

doi:10.1001/archderm.1988.01670090039008

Article

September 1988

Human Adjuvant Disease Following Augmentation Mammoplasty

Stephen J. Brozena, MD; Neil A. Fenske, MD; C. Wayne Cruse, MD; et al Carmen G. Espinoza, MD; Frank B. Vasey, MD; Bernard F. Germain, MD; Luis R. Espinoza, MD

Author Affiliations

From the Department of Internal Medicine, Divisions of Dermatology (Drs Brozena, Fenske, and C. Espinoza), and Rheumatology (Drs Vasey, Germain, and L. Espinoza); Department of Pathology (Drs Fenske and C. Espinoza); and Department of Surgery, Division of Plastic Surgery (Dr Cruse), University of South Florida College of Medicine and the James A. Haley Veterans Hospital, Tampa.

Arch Dermatol. 1988;124(9):1383-1386. doi:10.1001/archderm.1988.01670090039008

Full Text

Abstract

• Two patients are described in whom a progressive systemic sclerosis-like illness developed several years after silicone augmentation mammoplasty. Both had removal of breast implants, followed by marked-to-complete recovery from clinical abnormalities. This entity is increasingly recognized and has become known as human adjuvant disease.

(Arch Dermatol 1988;124:1383-1386)

Full Text

Human Adjuvant Disease Following Augmentation Mammoplasty

Others Also Liked

Featured Articles

USPSTF Recommendation Statements

Blogs

Human Adjuvant Disease Following Augmentation Mammoplasty

Citation

Download citation file:

Others Also Liked

Select Your Interests